These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9618045)

  • 1. Circulating levels in serum of total sialic acid, lipid-associated sialic acid, and fucose in precancerous lesion and cancer of the oral cavity.
    Rao VR; Krishnamoorthy L; Kumaraswamy SV; Ramaswamy G
    Cancer Detect Prev; 1998; 22(3):237-40. PubMed ID: 9618045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of serum fucose and serum sialic acid levels in oral squamous cell carcinomia.
    Shashikanth MC; Rao BB
    Indian J Dent Res; 1994; 5(4):119-24. PubMed ID: 9495093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of serum sialic acid, sialyltransferase and sialoproteins in oral cavity cancer.
    Raval GN; Patel DD; Parekh LJ; Patel JB; Shah MH; Patel PS
    Oral Dis; 2003 May; 9(3):119-28. PubMed ID: 12945593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of serum glycoconjugates in precancerous and cancerous diseases of the oral cavity.
    Baxi BR; Patel PS; Adhvaryu SG; Dayal PK
    Cancer; 1991 Jan; 67(1):135-40. PubMed ID: 1985709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of serum biomarkers (TSA & LSA) and epithelial dysplasia in early diagnosis of oral precancer and oral cancer.
    Sawhney H; Kumar CA
    Cancer Biomark; 2011-2012; 10(1):43-9. PubMed ID: 22297551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum sialic acid, fucose, sialic acid/fucose ratio as tumor markers in oral cancer.
    Ghosh M; Nayak BR
    Ann Dent; 1991; 50(2):33-5, 48. PubMed ID: 1785913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of total and lipid bound sialic acid levels in oral pre-cancerous conditions and oral cancer.
    Rajpura KB; Patel PS; Chawda JG; Shah RM
    J Oral Pathol Med; 2005 May; 34(5):263-7. PubMed ID: 15817068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salivary L-fucose as a biomarker for oral potentially malignant disorders and oral cancer.
    Sharma M; Sharma E; Prabhu V; Pai VR; D'souza JM; Harish S; Jose M
    J Cancer Res Ther; 2020; 16(3):546-550. PubMed ID: 32719265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation and comparative study of serum total sialic acid levels as tumor markers in oral cancer and precancer.
    Joshi M; Patil R
    J Cancer Res Ther; 2010; 6(3):263-6. PubMed ID: 21119250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of salivary sialic acid as a tumor marker in tobacco chewers with oral cancer.
    Azeem MS; Yesupatham ST; Mohiyuddin SMA; Sumanth V; Ravishankar S
    J Cancer Res Ther; 2020; 16(3):605-611. PubMed ID: 32719275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring carcinogenesis in a case of oral squamous cell carcinoma using a panel of new metabolic blood biomarkers as liquid biopsies.
    Grimm M; Hoefert S; Krimmel M; Biegner T; Feyen O; Teriete P; Reinert S
    Oral Maxillofac Surg; 2016 Sep; 20(3):295-302. PubMed ID: 26875085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of serum lipids and lipoproteins as prognosticators in leukoplakia.
    Ganavi BS; Patil S; Rao RS
    J Contemp Dent Pract; 2014 May; 15(3):294-9. PubMed ID: 25307809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of serum and salivary total sialic acid and α-l-fucosidase in patients with oral precancerous conditions and oral cancer.
    Vajaria BN; Patel KR; Begum R; Shah FD; Patel JB; Shukla SN; Patel PS
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Jun; 115(6):764-71. PubMed ID: 23570662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of serum sialic acid and carcinoembryonic antigen for the detection of early-stage colorectal cancer.
    Tautu C; Pee D; Dunsmore M; Prorok JJ; Alhadeff JA
    J Clin Lab Anal; 1991; 5(4):247-54. PubMed ID: 1890538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Serum Fucose Levels in Leukoplakia and Oral Cancer Patients.
    Rai NP; Anekar J; Shivaraja Shankara YM; Divakar DD; Al Kheraif AA; Ramakrishnaiah R; Sebastian R; Raj AC; Al-Hazmi A; Mustafa SM
    Asian Pac J Cancer Prev; 2015; 16(17):7497-500. PubMed ID: 26625751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum fucosylation changes in oral cancer and oral precancerous conditions: alpha-L-fucosidase as a marker.
    Shah M; Telang S; Raval G; Shah P; Patel PS
    Cancer; 2008 Jul; 113(2):336-46. PubMed ID: 18521898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sialic acid as a biomarker of oral potentially malignant disorders and oral cancer.
    Achalli S; Madi M; Babu SG; Shetty SR; Kumari S; Bhat S
    Indian J Dent Res; 2017; 28(4):395-399. PubMed ID: 28836530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of serum sialic acid, heat stable alkaline phosphatase and fucose as markers of breast carcinoma.
    Patel PS; Baxi BR; Adhvaryu SG; Balar DB
    Anticancer Res; 1990; 10(4):1071-4. PubMed ID: 2382978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total sialic acid as a tumor marker for oral cancer.
    Xing RD; Wang ZS; Li CQ; Tang QY; Jiang CB; Zhang YZ
    Int J Biol Markers; 1994; 9(4):239-42. PubMed ID: 7836802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total and lipid-bound serum sialic acid in children with malignancy or infections.
    Romppanen J; Petäjä J; Heikinheimo M; Mononen I
    Anticancer Res; 1998; 18(4B):2793-7. PubMed ID: 9713463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.